The Board of Directors of ASIT Biotech S.A. appointed Yves Désiront as interim CFO, while the company is looking for a new profile to replace Everard van der Straten, who supervised the financial organization of the company and its financing since its IPO in 2016. Everard van der Straten remains a Board member. Philippe Degeer to join the Board of Directors as representative of Meusinvest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0198 EUR | +3.12% | +3.12% | -15.74% |
21/04 | DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-15.74% | 31.22M | |
-18.17% | 8.55B | |
+87.40% | 4.63B | |
+16.31% | 2.98B | |
-3.15% | 2.65B | |
-2.10% | 1.89B | |
-53.27% | 1.81B | |
-12.97% | 1.56B | |
+21.59% | 1.27B | |
-47.96% | 1.07B |
- Stock Market
- Equities
- DMSIM Stock
- News European Medical Solutions
- ASIT Biotech S.A. Announces Executive Changes